Clinical manifestations in infants and children with Mycoplasma pneumoniae infection
- PMID: 29698412
- PMCID: PMC5919654
- DOI: 10.1371/journal.pone.0195288
Clinical manifestations in infants and children with Mycoplasma pneumoniae infection
Abstract
Background: Mycoplasma pneumoniae is a common cause of community-acquired pneumonia in older children. Pulmonary and extra-pulmonary symptoms associated with M. pneumoniae infection are reported. M. pneumoniae is mainly epidemic in Denmark with the recurrence every 4-7th year.
Aims: Retrospectively, to describe the epidemiology and clinical features, in infants and children, during the M. pneumoniae epidemic in 2010 and 2011.
Methods: All children under the age of 16 that were tested for M. pneumoniae during the period 01.02.2010-31.01.2012 were included. Medical charts, as well as radiological findings, were reviewed for all children with M. pneumoniae. A post-hoc analysis of viral co-infections was done on part of the cohort.
Results: 134 of 746 children were tested positive for M. pneumoniae by PCR or serology. Positive tests were found in 65% of children seven years and older, in 30% of 2-6-year-olds and 4% of infants (less than two years of age). Viral co-infection was found in 27% of the tested samples. The clinical presentation was a cough, asthma-like symptoms and low-grade fever. Extra-pulmonary symptoms were common and presented as nausea/vomiting by 33% of the children and skin manifestations by 25%. 84% of the children had a chest x-ray taken, and there were positive radiological findings in 94% of these.
Conclusion: M. pneumoniae also affected infants and young children and symptoms were similar to infections with respiratory viruses, but severe LRTI were also seen. During an up-coming epidemic, assessment of extra-pulmonary manifestations can be helpful when diagnosing M. pneumoniae infections.
Conflict of interest statement
Figures
Similar articles
-
Clinical characteristics of children with Mycoplasma pneumoniae infection hospitalized during the Danish 2010-2012 epidemic.Dan Med J. 2013 May;60(5):A4632. Dan Med J. 2013. PMID: 23673264
-
Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia.BMC Infect Dis. 2020 Aug 26;20(1):633. doi: 10.1186/s12879-020-05356-1. BMC Infect Dis. 2020. PMID: 32847534 Free PMC article.
-
Epidemiology and clinical profiles of Mycoplasma pneumoniae infection in hospitalized infants younger than one year.Respir Med. 2015 Jun;109(6):751-7. doi: 10.1016/j.rmed.2015.04.006. Epub 2015 Apr 25. Respir Med. 2015. PMID: 25957828
-
Infection by Mycoplasma pneumoniae and its importance as an etiological agent in childhood community-acquired pneumonias.Braz J Infect Dis. 2007 Oct;11(5):507-14. doi: 10.1590/s1413-86702007000500012. Braz J Infect Dis. 2007. PMID: 17962878 Review.
-
A comprehensive review of Mycoplasma pneumoniae infection in chronic lung diseases: recent advances in understanding asthma, COPD, and bronchiectasis.Front Med (Lausanne). 2024 Sep 25;11:1437731. doi: 10.3389/fmed.2024.1437731. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39386750 Free PMC article. Review.
Cited by
-
Pinocembrin Relieves Mycoplasma pneumoniae Infection‑Induced Pneumonia in Mice Through the Inhibition of Oxidative Stress and Inflammatory Response.Appl Biochem Biotechnol. 2022 Dec;194(12):6335-6348. doi: 10.1007/s12010-022-04081-6. Epub 2022 Aug 2. Appl Biochem Biotechnol. 2022. PMID: 35917101
-
Serum sTREM-1 and CXCL-16 Levels in Children with Mycoplasma pneumoniae Pneumonia and Their Diagnostic Value.Evid Based Complement Alternat Med. 2021 Oct 13;2021:7179796. doi: 10.1155/2021/7179796. eCollection 2021. Evid Based Complement Alternat Med. 2021. Retraction in: Evid Based Complement Alternat Med. 2023 Dec 13;2023:9807370. doi: 10.1155/2023/9807370. PMID: 34691220 Free PMC article. Retracted.
-
Increasing Age Affected Polymorphonuclear Neutrophils in Prognosis of Mycoplasma pneumoniae Pneumonia.J Inflamm Res. 2021 Aug 14;14:3933-3943. doi: 10.2147/JIR.S321656. eCollection 2021. J Inflamm Res. 2021. PMID: 34429628 Free PMC article.
-
[Molecular detection of Mycoplasma pneumoniae in respiratory samples from hospitalized children].Rev Fac Cien Med Univ Nac Cordoba. 2023 Mar 31;80(1):20-24. doi: 10.31053/1853.0605.v80.n1.37514. Rev Fac Cien Med Univ Nac Cordoba. 2023. PMID: 37018359 Free PMC article. Spanish.
-
Epidemiological and clinical analysis of community-acquired Mycoplasma pneumonia in children from a Spanish population, 2010-2015.An Pediatr (Engl Ed). 2019 Jul;91(1):21-29. doi: 10.1016/j.anpede.2019.01.003. Epub 2019 Feb 6. An Pediatr (Engl Ed). 2019. PMID: 32289046 Free PMC article.
References
-
- Waites KB. New concepts of Mycoplasma pneumoniae infections in children. Pediatr Pulmonol. 2003;36: 267–278. doi: 10.1002/ppul.10346 - DOI - PubMed
-
- Hornsleth A. [The virology of acute respiratory tract infections. 1. A survey on the etiology in children]. Ugeskr Laeger. 1967;129: 1253–1258. - PubMed
-
- Hornsleth A. [The virology of acute respiratory tract infections. 2. Isolation of viruses in hospitalized children]. Ugeskr Laeger. 1967;129: 1259–1265. - PubMed
-
- Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M, et al. British Thoracic Society guidelines for the management of community-acquired pneumonia in children: update 2011. Thorax. 2011;66 Suppl 2: ii1–23. doi: 10.1136/thoraxjnl-2011-200598 - DOI - PubMed
-
- Zalenzink D, Vallejo J. Mycoplasma pneumonia infection in children. 2009th ed. UpToDate.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical